Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Lancet HIV. 2021 Sep 9;8(10):e614–e622. doi: 10.1016/S2352-3018(21)00158-2

Table 3:

Baseline characteristics of adolescents and young adults living with HIV who developed cancer or remained free of cancer.

Any cancer Kaposi sarcoma Cervical cancer Non-Hodgkin
lymphoma
Hodgkin
lymphoma
Leukaemia Free of cancer
N=867 N=429 N=45 N=107 N=48 N=32 N=781,587
Age
 15-19 years 231 (26.6) 108 (25.2) 13 (28.9) 25 (23.4) 15 (31.2) 9 (28.1) 175,788 (22.5)
 20-24 years 636 (73.4) 321 (74.8) 32 (71.1) 82 (76.6) 33 (68.8) 23 (71.9) 605,799 (77.5)
Sex
 Female 700 (80.7) 347 (80.9) 45 (100.0) 78 (72.9) 32 (66.7) 20 (62.5) 697,366 (89.2)
 Male 167 (19.3) 82 (19.1) 0 29 (27.1) 16 (33.3) 12 (37.5) 84,221 (10.8)
Calendar period
 2004 - 2007 282 (32.5) 152 (35.4) 13 (28.9) 32 (29.9) 18 (37.5) 11 (34.4) 167,932 (21.5)
 2008 - 2011 423 (48.8) 206 (48.0) 27 (60.0) 49 (45.8) 20 (41.7) 17 (53.1) 396,989 (50.8)
 2012 - 2014 162 (18.7) 71 (16.6) 5 (11.1) 26 (24.3) 10 (20.8) 4 (12.5) 216,666 (27.7)
Median CD4 cell count [IQR] [cells/μL] 248 [121, 399] 207 [84, 350] 261 [168, 361] 240 [139, 345] 267 [147, 447] 385 [208, 806] 357 [224, 520]
CD4 cell count [cells/μL]
 <200 293 (33.8) 179 (41.7) 15 (33.3) 37 (34.6) 15 (31.2) 6 (18.8) 147,652 (18.9)
 200-499 338 (39.0) 158 (36.8) 19 (42.2) 42 (39.3) 17 (35.4) 11 (34.4) 364,579 (46.6)
 ≥500 127 (14.6) 42 (9.8) 5 (11.1) 14 (13.1) 10 (20.8) 11 (34.4) 194,531 (24.9)
 Missing 109 (12.6) 50 (11.7) 6 (13.3) 14 (13.1) 6 (12.5) 4 (12.5) 74,825 (9.6)
HIV RNA viral load [copies/ml]
 <1,000 44 (5.1) 15 (3.5) 3 (6.7) 8 (7.5) 3 (6.2) 3 (9.4) 40,988 (5.2)
 ≥1,000 76 (8.8) 47 (11.0) 3 (6.7) 11 (10.3) 3 (6.2) 2 (6.2) 44,753 (5.7)
 Missing 747 (86.2) 367 (85.5) 39 (86.7) 88 (82.2) 42 (87.5) 27 (84.4) 695,846 (89.0)

Results are presented as counts and percentages if not otherwise stated.